No Data
No Data
康基醫療:2023年度報告
KANGJI MEDICAL To Go Ex-Dividend On May 29th, 2024 With 0.45193 HKD Dividend Per Share And 1.09125 HKD Special Dividend Per Share
March 21st - $KANGJI MEDICAL(09997.HK)$ is trading ex-dividend on May 29th, 2024. Shareholders of record on May 30th, 2024 will receive 0.45193 HKD dividend per share and 1.09125 HKD special divid
Kangji Medical Holdings' Profit Rises 5% in 2023
Kangji Medical Holdings' (HKG:9997) attributable profit increased 5.3% to 504 million yuan, or 0.4299 yuan per share, in 2023, from 478.7 million yuan, or 0.3963 yuan per share, in 2022, according to
Changes in Hong Kong stocks | Kangji Healthcare (09997) fell more than 5% in the morning, net profit for the whole year increased by 5.3%, and the company cancelled the merger of Weijing Healthcare
Kangji Healthcare (09997) opened high and went low in early trading, falling more than 5% in the morning. As of press release, it was down 4.99% to HK$7.05, with a turnover of HK$23.9852 million.
Kangji Healthcare (09997) announced its 2023 annual results. Profit attributable to shareholders was 504 million yuan, an increase of 5.3% over the previous year
Kangji Healthcare (09997) announced its annual results for the year ended December 31, 2023, with revenue of 926 million yuan (...
Kangji Healthcare (09997.HK) cancels merger with Weijing Healthcare
Gelonghui, March 20, 丨 Kangji Medical (09997.HK) announced that on March 20, 2024, Weijing Healthcare shareholders have approved several amendments to Weijing Healthcare's organizational rules and changes in the composition of the board of directors. According to the revised Articles of Association of Weizheng Healthcare, the number of directors that Kangji Hong Kong is authorized to appoint has been reduced from 4 to 3 of the 7 directors of Weijing Healthcare's board of directors. As a result, Kangji Hong Kong will no longer be able to appoint most of the board members of Weijing Healthcare and will lose control of Weijing Healthcare. After the change in the composition of the board of directors takes effect, Weijing Medical will no longer be a subsidiary of the company, and Weijing Medical's finances
No Data